New to Medtech Insight?
Start a free trial today!
Register for our free email digests:
Register for our free email digests:
Brought to you by 
Kensey Nash buys Synthes' Norian for $22mm in cash
May 2011
Executive Summary
Kensey Nash Corp. is acquiring orthopedic device maker Synthes Inc.'s Norian Corp. subsidiary for $22mm in cash--consisting of $11mm up front, and $11mm upon either transfer of manufacturing operations to Kensey Nash or 18 months following the closing, whichever comes first.
Deal Industry
- Biotechnology
-
Medical Devices
- Biomaterials
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Intra-Biotech Deal
- Acquisition of Private Biotech
- Includes Contract
- Full Acquisition
- Payment Includes Cash
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Kensey Nash buys Synthes' Norian for $22mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice